Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy
- 1 January 1997
- journal article
- clinical trial
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 71 (1), 73-80
- https://doi.org/10.1016/s0301-2115(96)02612-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- The vaginal epithelium in the postmenopause — cytology, histology and pH as methods of assessmentMaturitas, 1995
- Release of 17-Beta-Oestradiol from a Vaginal Ring in Postmenopausal Women: Pharmacokinetic EvaluationGynecologic and Obstetric Investigation, 1994
- Factors influencing vaginal cytology, pH and bacterial flora in elderly womenActa Obstetricia et Gynecologica Scandinavica, 1993
- Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophyMaturitas, 1993
- Low-dose 17β-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled studyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1992
- Effects of vaginally-administered oestriol on post-menopausal urogenital disorders: a cytohormonal studyMaturitas, 1992
- Vaginal rings for continuous low-dose release of oestradiol in the treatment of urogenital atrophyMaturitas, 1989
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987
- A clinical evaluation of treatment with estriol vaginal cream versus suppository in postmenopausal womenActa Obstetricia et Gynecologica Scandinavica, 1983
- The treatment of postmenopausal vaginal atrophy with Ovestin vaginal cream or suppositories: clinical, endocrinological and safety aspectsMaturitas, 1980